As the Q4 2024 pharma earnings period rolls on through the first month of President Donald Trump’s second term, executives ...

With just one asset in weight loss moving through the clinic, Pfizer targets the space for potential dealmaking, as well as bringing assets over from China.

CEO Bourla sees "a lot of opportunities that probably outweigh the risks" with the Trump administration, like working together on cancer treatments ...

IDRx chair Ben Auspitz took on a new investing role at Curie.Bio. Biogen appointed Novartis alum Adam ... from a New York residence where he does not legally reside. Pfizer CEO Albert Bourla and ...

Pfizer CEO Albert Bourla said there are "opportunities that probably outweigh the risks" of the Trump administration's ...

Few CEOs know the double-edged nature of dealing with US President Donald Trump as viscerally as Pfizer’s Albert Bourla. In his first term, Trump championed the $18 billion Operation Warp Speed ...

Pfizer CEO Albert Bourla revealed to stakeholders this week that the rendezvous took place in December, a few weeks after RFK Jr was nominated to head the Department of Health and Human Services ...

Pfizer's CEO Albert Bourla said that he's had dinner with Trump's health secretary pick, RFK Jr. Bourla said he was "cautiously optimistic" about the new administration. Kennedy is now close to ...

Pfizer's CEO said that he had dinner with President Donald Trump's pick for health secretary, Robert F. Kennedy Jr. In a Tuesday earnings call, CEO Albert Bourla said Trump had introduced him to ...